These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28287460)

  • 1. CDC25 Inhibition in Acute Myeloid Leukemia-A Study of Patient Heterogeneity and the Effects of Different Inhibitors.
    Brenner AK; Reikvam H; Rye KP; Hagen KM; Lavecchia A; Bruserud Ø
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28287460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antileukaemic effect of PI3K-mTOR inhibitors in acute myeloid leukaemia-gene expression profiles reveal CDC25B expression as determinate of pharmacological effect.
    Reikvam H; Tamburini J; Skrede S; Holdhus R; Poulain L; Ersvaer E; Hatfield KJ; Bruserud Ø
    Br J Haematol; 2014 Jan; 164(2):200-11. PubMed ID: 24383842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia--the possibility to target several kinases through inhibition of the various CDC25 isoforms.
    Brenner AK; Reikvam H; Lavecchia A; Bruserud Ø
    Molecules; 2014 Nov; 19(11):18414-47. PubMed ID: 25397735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia.
    Bertoli S; Boutzen H; David L; Larrue C; Vergez F; Fernandez-Vidal A; Yuan L; Hospital MA; Tamburini J; Demur C; Delabesse E; Saland E; Sarry JE; Galcera MO; Mansat-De Mas V; Didier C; Dozier C; Récher C; Manenti S
    Oncotarget; 2015 Nov; 6(35):38061-78. PubMed ID: 26515730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel synthetic inhibitor of CDC25 phosphatases: BN82002.
    Brezak MC; Quaranta M; Mondésert O; Galcera MO; Lavergne O; Alby F; Cazales M; Baldin V; Thurieau C; Harnett J; Lanco C; Kasprzyk PG; Prevost GP; Ducommun B
    Cancer Res; 2004 May; 64(9):3320-5. PubMed ID: 15126376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-based chemoinformatic discovery of a novel small molecule inhibitor targeting CDC25 dual specificity phosphatases and displaying in vitro efficacy against melanoma cells.
    Capasso A; Cerchia C; Di Giovanni C; Granato G; Albano F; Romano S; De Vendittis E; Ruocco MR; Lavecchia A
    Oncotarget; 2015 Nov; 6(37):40202-22. PubMed ID: 26474275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia.
    Min C; Moore N; Shearstone JR; Quayle SN; Huang P; van Duzer JH; Jarpe MB; Jones SS; Yang M
    PLoS One; 2017; 12(1):e0169128. PubMed ID: 28060870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Cellular Metabolism in Acute Myeloid Leukemia and The Role of Patient Heterogeneity.
    Grønningsæter IS; Reikvam H; Aasebø E; Bartaula-Brevik S; Tvedt TH; Bruserud Ø; Hatfield KJ
    Cells; 2020 May; 9(5):. PubMed ID: 32392896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional repression of Cdc25B by IER5 inhibits the proliferation of leukemic progenitor cells through NF-YB and p300 in acute myeloid leukemia.
    Nakamura S; Nagata Y; Tan L; Takemura T; Shibata K; Fujie M; Fujisawa S; Tanaka Y; Toda M; Makita R; Tsunekawa K; Yamada M; Yamaoka M; Yamashita J; Ohnishi K; Yamashita M
    PLoS One; 2011; 6(11):e28011. PubMed ID: 22132193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic small molecule Cdc25 phosphatases inhibitors.
    Garuti L; Roberti M; Pizzirani D
    Curr Med Chem; 2008; 15(6):573-80. PubMed ID: 18336271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
    Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
    Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties.
    Braud E; Goddard ML; Kolb S; Brun MP; Mondésert O; Quaranta M; Gresh N; Ducommun B; Garbay C
    Bioorg Med Chem; 2008 Oct; 16(19):9040-9. PubMed ID: 18789703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.
    De Luca L; Trino S; Laurenzana I; Tagliaferri D; Falco G; Grieco V; Bianchino G; Nozza F; Campia V; D'Alessio F; La Rocca F; Caivano A; Villani O; Cilloni D; Musto P; Del Vecchio L
    Cell Death Dis; 2017 Jun; 8(6):e2849. PubMed ID: 28569789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia - identification of responders by gene expression profiling of pretreatment leukemic cells.
    Reikvam H; Hovland R; Forthun RB; Erdal S; Gjertsen BT; Fredly H; Bruserud Ø
    BMC Cancer; 2017 Sep; 17(1):630. PubMed ID: 28877686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vacuolar ATPase as a possible therapeutic target in human acute myeloid leukemia.
    Aasebø E; Bartaula-Brevik S; Hernandez-Valladares M; Bruserud Ø
    Expert Rev Hematol; 2018 Jan; 11(1):13-24. PubMed ID: 29168399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity.
    Brun MP; Braud E; Angotti D; Mondésert O; Quaranta M; Montes M; Miteva M; Gresh N; Ducommun B; Garbay C
    Bioorg Med Chem; 2005 Aug; 13(16):4871-9. PubMed ID: 15921913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia.
    Lipreri da Silva JC; Coelho-Silva JL; Lima K; Vicari HP; Lazarini M; Costa-Lotufo LV; Traina F; Machado-Neto JA
    Cell Oncol (Dordr); 2021 Oct; 44(5):1105-1117. PubMed ID: 34196912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypophosphorylation of pRB and repression of cyclin D3 and cdc25A during the granulocytic differentiation of human myeloblastic leukemia ML-1 cells.
    Ludlow JW
    Leuk Res; 1999 Oct; 23(10):909-11. PubMed ID: 10573136
    [No Abstract]   [Full Text] [Related]  

  • 19. ADCY7 supports development of acute myeloid leukemia.
    Li C; Xie J; Lu Z; Chen C; Yin Y; Zhan R; Fang Y; Hu X; Zhang CC
    Biochem Biophys Res Commun; 2015 Sep; 465(1):47-52. PubMed ID: 26220344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia.
    Garg S; Shanmukhaiah C; Marathe S; Mishra P; Babu Rao V; Ghosh K; Madkaikar M
    Eur J Haematol; 2016 Mar; 96(3):309-17. PubMed ID: 26010294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.